Brazil's Anvisa network expands with spectroscopy centre:
This article was originally published in Clinica
Executive Summary
Brazilian healthcare surveillance agency Anvisa has expanded its network of laboratories with a spectroscopy centre in Santa Maria, Rio Grande do Sul. The centre will specialise in atomic and molecular spectroscopy, which are used to regulate the quality of bioscientific material. Anvisa invested R$2.2m (US$1m) in the centre, as part of an ongoing programme of improvements to the infrastructure of its laboratory network.
You may also be interested in...
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Stakeholders Devise Six-Point Plan To Improve Cross-Border Clinical Trials
Sponsors need guidance on ethics requirements and clarity around national regulations to conduct cross-border clinical trials in the EU, a multi-stakeholder forum says.
Normality Reasserts Itself For Biotech IPOs
The highs of the COVID-19 era, and the lows that supplanted it, are beginning to fade.